Kathleen Hoffman, Author at Medivizor - Page 40 of 88
Navigation Menu

Knowledge is Power: Help For People With Hodgkin’s Lymphoma

Knowledge is Power: Help For People With Hodgkin’s Lymphoma

Posted by on Jun 12, 2017 in Blog, Hodgkin's lymphoma | 1 comment

“Family and friends can be great sources of support but truth be told, no one can ever really know what you are going through other than those who have been there themselves….” ~Rachele Chaar Ghosn For Rachele Chaar Ghosn, a 24-year-old woman with Hodgkin’s Lymphoma, finding others going through treatment for Hodgkins was paramount....

Read More

Chocolate, Need I Say More…

Chocolate, Need I Say More…

Posted by on Jun 6, 2017 in Blog, Coronary artery disease, Hypertension, Stroke | 1 comment

Recently published, another research article about the benefits of chocolate!  In this case, the Danish are following a large group of people, ages 50 to 64 over a number of years to find out how their consumption of chocolate affects their health.  In this study, they looked at atrial fibrillation, a condition in which the upper chambers of your heart...

Read More

Over 13 Facts About Bones-Medivizor

Over 13 Facts About Bones-Medivizor

Posted by on May 31, 2017 in Blog | 2 comments

We don’t think about them but our bones give our bodies, our internal organs and our muscles, structure and protection.  Your skeleton is the birthplace of blood cells.  And it store minerals that are essential to life.   What Mom Never Told You About Osteoporosis! is a post that describes the composition of bones.  Here is a cross section of a...

Read More

Quick Guide: Understanding the Importance of the FDA’s Keytruda Approval

Quick Guide:  Understanding the Importance of the FDA’s Keytruda Approval

Posted by on May 26, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Lung cancer, Melanoma, Prostate cancer | 2 comments

In July 2015, we published a post called Patients Included In Research: Studying Cancer by Mutation Not Organ.  In that post, we shared the goal that cancers would be treated not by the site of origin, but rather by their genetic features.  Achieving this goal is closer than you think! This week the FDA announced accelerated approval** of a...

Read More